Shipping Update - 08.10.2025

We’ll begin processing and shipping all pending orders around 2:00 PM today.

The past few days have been incredibly busy – we had to prepare a lot of stock to make sure every order goes out smoothly. Demand is currently at an all-time high.

In our last update, we mentioned that order volume had already reached about four times the previous peak. Since then, it has doubled again – we’re now handling roughly eight times more orders than ever before!

We truly appreciate your patience and trust. You’re amazing, and we’re doing everything we can to get your packages shipped as quickly as possible.

This article is directly related to one or more of our products – for example, with regard to batches, availability, or quality updates.

We only provide such information via our news.

On the linked product page, you will find additional details about the product and can order or pre-order it directly there.

Available Immediately

With its dual action as a mu-opioid receptor agonist and norepinephrine reuptake inhibitor, O-DSMT HCL is a versatile research opioid.

The compound is primarily used in studies on tramadol metabolism, receptor affinity, and the absence of serotonergic activity, making it of interest for developing opioid-based substances with improved side effect profiles.

Our version of O-DSMT HCL is produced to the highest standards in a specialized partner laboratory and is laboratory-tested for high purity.

Available Immediately

IC-26 HCL, a structural analogue of methadone, acts as a mu-opioid receptor agonist and is used in research to explore structural modifications within the opioid class.

The substitution of the carbonyl group with a sulfonyl group makes IC-26 HCL particularly valuable for comparative analyses and studies on receptor binding and pharmacodynamics.

Our IC-26 HCL is synthesized exclusively through our partner laboratory, produced to a high-purity standard, and rigorously tested internally for identity and purity.

Available Immediately

SR-17018 HCL is a functionally selective mu-opioid receptor agonist that has attracted significant interest in preclinical research due to its innovative mechanism of action.

The compound is being studied for its potential to provide analgesia with a reduced incidence of typical opioid-related side effects and is suitable for studies on receptor binding dynamics, signal transduction, and biased agonism.

Our SR-17018 HCL is produced exclusively through our partner laboratory and stands out for its exceptionally high chemical purity and batch consistency.

Optional cookies accepted

Thank you for choosing to accept optional cookies!

This helps us to continually improve your user experience on our website. These cookies enable us to gain valuable insights into which pages and processes are particularly relevant for our users.

This way we ensure that the content and functions of our website are optimally tailored to your needs and that we can offer you an all-round successful visitor experience.